Paper4903501
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Ferebee SH. Bibl Tuberc, 1970. Cited by 372 papers, by iCite.
Cite this record
ConductScience Library. Controlled chemoprophylaxis trials in tuberculosis. A general review. Papers, record 4903501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4903501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics33
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Isoniazid | Major topic |
| Tuberculosis | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Alaska | |
| Anemia | |
| Child | |
| Child, Preschool | |
| Clinical Trials as Topic | |
| Drug Hypersensitivity | |
| Drug Resistance, Microbial | |
| Epilepsy | |
| Female | |
| Follow-Up Studies | |
| Greenland | |
| Humans | |
| Japan | |
| Kenya | |
| Male | |
| Mental Processes | |
| Middle Aged | |
| Neoplasms | |
| Netherlands | |
| New York | |
| Philippines | |
| Placebos | |
| Pregnancy | |
| Tuberculin Test | |
| Tuberculosis, Pulmonary | |
| Tunisia | |
| United States | |
| United States Public Health Service |
Source PubMed
Cited by209
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 372 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42638735 | Tuberculosis: insights into latency, treatment strategies, and the potential roles of metronidazole. | Front Tuberc | 2023 | https://conductscience.org/library/papers/42638735 | PubMed |
| 42625659 | Machine learning-based feature selection suggests circulating proteins as best at predicting and diagnosing tuberculosis in Mycobacterium tuberculosis-exposed rhesus macaques. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42625659 | PubMed |
| 41642936 | Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study. | PLoS Med | 2026 | https://conductscience.org/library/papers/41642936 | PubMed |
| 41623531 | Long-Term Case-Finding of Latent Tuberculosis Infection Among Household Contacts to Support Tuberculosis Elimination Efforts in Indonesia. | Mater Sociomed | 2025 | https://conductscience.org/library/papers/41623531 | PubMed |
| 40986702 | The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis. | Am J Respir Crit Care Med | 2026 | https://conductscience.org/library/papers/40986702 | PubMed |
| 40565607 | Identification of Gene Expression Biomarkers Predictive of Latent Tuberculosis Infection Using Machine Learning Approaches. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40565607 | PubMed |
| 39909102 | Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States. | Chest | 2025 | https://conductscience.org/library/papers/39909102 | PubMed |
| 39733063 | Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review. | Drugs | 2025 | https://conductscience.org/library/papers/39733063 | PubMed |
| 39364056 | Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39364056 | PubMed |
| 39151980 | Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study. | Lancet Glob Health | 2024 | https://conductscience.org/library/papers/39151980 | PubMed |
| 39048129 | Overlooked, dismissed, and downplayed: reversion of Mycobacterium tuberculosis immunoreactivity. | Eur Respir Rev | 2024 | https://conductscience.org/library/papers/39048129 | PubMed |
| 38954723 | Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence. | PLOS Glob Public Health | 2024 | https://conductscience.org/library/papers/38954723 | PubMed |
| 38454178 | Outcomes for people with TB by disease severity at presentation. | Int J Tuberc Lung Dis | 2024 | https://conductscience.org/library/papers/38454178 | PubMed |
| 38095783 | Tuberculosis Preventive Treatment. | Indian J Pediatr | 2024 | https://conductscience.org/library/papers/38095783 | PubMed |
| 37963250 | Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37963250 | PubMed |
| 37919487 | Current Epidemiology of Pediatric Tuberculosis. | Indian J Pediatr | 2024 | https://conductscience.org/library/papers/37919487 | PubMed |
| 37491264 | Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB). | Trials | 2023 | https://conductscience.org/library/papers/37491264 | PubMed |
| 37477042 | Schwalb and Houben Respond to "The Winding Road to ARTI". | Am J Epidemiol | 2023 | https://conductscience.org/library/papers/37477042 | PubMed |
| 36240830 | Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania. | Lancet Glob Health | 2022 | https://conductscience.org/library/papers/36240830 | PubMed |
| 36165624 | To Err Is Human, to Forgive Is Pharmacodynamic. | Am J Respir Crit Care Med | 2023 | https://conductscience.org/library/papers/36165624 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4903501
GET https://conductscience.org/api/papers/v1/4903501/cited_by?page=2